secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001104659-23-074014
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics appoints Alethia Young as CFO, replaces Lee Kalowski
-------------------------------------------------------------------------

- Alethia Young appointed CFO effective ~July 17, 2023; Lee Kalowski resigned effective June 22, 2023.
- Young previously CFO of Graphite Bio (GRPH) and biotech analyst at Cantor, Credit Suisse, Deutsche Bank.
- Young receives base salary $480,000, bonus target 50%, signing bonus $100,000, option for 120,000 shares.
- Travis Thompson appointed Chief Accounting Officer effective June 22, 2023; joined company in 2018.
- No family relationships or related-party transactions between new officers and company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465923074014/0001104659-23-074014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465923074014/tm2319507d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-074014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer